Seeking Alpha
22 Oct 2026, 03:58 UTC · 2h ago
Elevance Health: Better Results, But Not Enough To Buy
Impact · against what's priced in
The update is neutral to slightly positive but fails to trigger a re-rating because the market is explicitly ignoring a margin recovery. While guidance is up, the persistent pressure in Medicaid confirms the market's current assumption that profitability compression is structural rather than temporary.
- ELV+0.00
Already priced in
- The price assumes
structural operating margin of roughly 4.1% and a thin 1.6% free-cash-flow margin
The continued pressure on Health Benefits margins, specifically in Medicaid, aligns with the current valuation which assumes profitability compression is permanent.
What ELV's price assumes · Aug 27
